Find the Right Market Report

Search thousands of industry reports, market insights, and research studies in one place.

Not sure where to start? Try one of these:
Explore healthcare market intelligence and industry insights
Towards Healthcare

Small Molecule Drug Discovery Outsourcing Market Growth Driven by AI and R&D Advancements

Date : 07 April 2026

Companie's Offerings in the Small Molecule Drug Discovery Outsourcing Market

Small Molecule Drug Discovery Outsourcing Market Companies are WuXi AppTec, Charles River Laboratories, Evotec SE, Pharmaron, Eurofins Scientific, Labcorp Drug Development

Understand your market before making decisions - Download a free tailored report sample today.

Company Description
WuXi AppTec Its offerings include a fully integrated chemistry & biology platform.
Charles River Laboratories This firm offers entire early-stage discovery, in vitro, and in vivo pharmacology services, like an AI-powered drug discovery alliance (Logica) with Valo Health.
Evotec SE A company specializes in high-throughput screening and multi-omics.
Pharmaron This leader focuses on medicinal chemistry, biosciences, & DMPK.
Eurofins Scientific It facilitates ADME-Tox, pharmacology, & phenotypic screening services.
Labcorp Drug Development It is popular for robust nonclinical testing services, toxicology, & integration of diagnostics with preclinical discovery.
Syngene International Ltd Its offering covers integrated R&D services, specializing in medicinal chemistry & safety evaluation.
Curia Global This specializes in complex chemical synthesis, high-throughput screening, and drug discovery biology.
Selvita A CRO offers integrated drug discovery, especially in oncology and inflammation.
Viva Biotech This provides structure-based drug discovery (SBDD), with top-tier protein production & X-ray crystallography.

Key Developments in the Small Molecule Drug Discovery Outsourcing Market

  • In February 2026, SCIEX rolled out the Echo MS+ system, a high-throughput analytical solution to improve sensitivity.
  • In September 2025, Peapod Bio Inc. unveiled small molecule assay development and high-throughput screening (HTS) services leveraging label-free & optical technologies.
  • In May 2025, Inductive Bio raised $25M Series A to revolutionize small molecule drug discovery with an industry-wide AI platform.

Small Molecule Drug Discovery Outsourcing Market- Supply Chain Analysis

R&D

  • This prominently follows target validation, high-throughput screening (HTS), hit-to-lead optimization, ADME/Tox studies, & preclinical.
  • Key Players: WuXi AppTec, CRL, Evotec, etc.

Clinical Trials & Regulatory Approvals

  • This mainly covers preclinical lead optimization, IND-enabling animal studies, & phase-appropriate GMP manufacturing, with complex regulatory guidelines for IND/NDA submissions, audit readiness, & phase I-IV trials.
  • Key Players: Insilico Medicine, Schrodinger, Syngene International, etc.

Formulation and Final Dosage Preparation

  • Researchers follow characterization, formulation development, pilot scale-up and clinical trial material (CTM) production, & finally, packaging & stability studies.
  • Key Players: Lonza, Catalent, Eurofins CDMO, etc. 

The global small molecule drug discovery outsourcing market size was estimated at USD 8.9 billion in 2025 and is predicted to increase from USD 9.67 billion in 2026 to approximately USD 20.5 billion by 2035, expanding at a CAGR of 8.7% from 2026 to 2035. The overall growth is fueled by the cost-effectiveness of outsourcing, the involvement of skilled expertise, & the wider use of advanced technologies. Eventual developments will pose increased applications of AI, machine learning, & computer aided drug design solutions in the ongoing innovations.

Small Molecule Drug Discovery Outsourcing Market Size is USD 9.67 Billion in 2026.

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.

Talk to an Analyst Contact Sales